ITBO910114A1 - Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. - Google Patents

Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.

Info

Publication number
ITBO910114A1
ITBO910114A1 IT000114A ITBO910114A ITBO910114A1 IT BO910114 A1 ITBO910114 A1 IT BO910114A1 IT 000114 A IT000114 A IT 000114A IT BO910114 A ITBO910114 A IT BO910114A IT BO910114 A1 ITBO910114 A1 IT BO910114A1
Authority
IT
Italy
Prior art keywords
salts
controlled release
pharmaceutical formulations
oral use
bile acids
Prior art date
Application number
IT000114A
Other languages
English (en)
Inventor
Egidio Marchi
Leone Gabriele Rotini
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO910114A0 publication Critical patent/ITBO910114A0/it
Priority to ITBO910114A priority Critical patent/IT1245891B/it
Priority to US07/861,462 priority patent/US5300300A/en
Priority to EP92105717A priority patent/EP0508312B1/en
Priority to ES92105717T priority patent/ES2091970T3/es
Priority to TW081102518A priority patent/TW215899B/zh
Priority to DE69213800T priority patent/DE69213800T2/de
Priority to CA002065652A priority patent/CA2065652C/en
Priority to JP4091131A priority patent/JP2509046B2/ja
Priority to KR1019920006053A priority patent/KR970005177B1/ko
Publication of ITBO910114A1 publication Critical patent/ITBO910114A1/it
Application granted granted Critical
Publication of IT1245891B publication Critical patent/IT1245891B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITBO910114A 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. IT1245891B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US07/861,462 US5300300A (en) 1991-04-12 1992-04-01 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
TW081102518A TW215899B (it) 1991-04-12 1992-04-02
ES92105717T ES2091970T3 (es) 1991-04-12 1992-04-02 Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.
EP92105717A EP0508312B1 (en) 1991-04-12 1992-04-02 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
DE69213800T DE69213800T2 (de) 1991-04-12 1992-04-02 Oral anzuwendende magensaftstabile Arzneimittel mit gesteuerter Wirkstoffabgabe enthaltend Gallensäuren und deren Salze
CA002065652A CA2065652C (en) 1991-04-12 1992-04-10 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
JP4091131A JP2509046B2 (ja) 1991-04-12 1992-04-10 胆汁酸およびその塩を含有する経口投与用の放出制御型胃液耐性製剤
KR1019920006053A KR970005177B1 (ko) 1991-04-12 1992-04-11 담즙산과 그 염을 함유하는 경구용 방출제어 위내성 위약 의약 포뮬레이션

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.

Publications (3)

Publication Number Publication Date
ITBO910114A0 ITBO910114A0 (it) 1991-04-12
ITBO910114A1 true ITBO910114A1 (it) 1992-10-12
IT1245891B IT1245891B (it) 1994-10-25

Family

ID=11337392

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.

Country Status (9)

Country Link
US (1) US5300300A (it)
EP (1) EP0508312B1 (it)
JP (1) JP2509046B2 (it)
KR (1) KR970005177B1 (it)
CA (1) CA2065652C (it)
DE (1) DE69213800T2 (it)
ES (1) ES2091970T3 (it)
IT (1) IT1245891B (it)
TW (1) TW215899B (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
IT1255968B (it) * 1992-11-27 1995-11-17 Composizioni farmaceutiche contenenti acido ursodesossicolico
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
RU2224523C2 (ru) 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
WO2001056547A2 (en) * 2000-02-04 2001-08-09 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US6821931B2 (en) * 2002-03-05 2004-11-23 Alpine Mud Products Corporation Water-based drilling fluid additive containing talc and carrier
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
EP1696910A4 (en) * 2003-09-26 2009-12-09 Smithkline Beecham Corp COMPOSITIONS AND METHOD FOR THE TREATMENT OF FIBROSIS
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
JP2008511651A (ja) * 2004-08-30 2008-04-17 セオ ホン ユー 局所虚血モデルでの可溶化udcaの神経保護効果
BRPI0518191A (pt) * 2004-10-15 2008-11-04 Seo Hong Yoo métodos e composições para reduzir a toxicidade de um composto farmacêutico
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
SI2124884T1 (sl) * 2006-12-22 2019-09-30 Ironwood Pharmaceuticals, Inc. Pripravki, ki obsegajo sekvestrante žolčnih kislin, za zdravljenje motenj požiralnika
KR101636958B1 (ko) * 2009-09-11 2016-07-06 주식회사 대웅제약 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
EP2765998A1 (en) 2011-10-11 2014-08-20 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
IT1212141B (it) 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.

Also Published As

Publication number Publication date
CA2065652A1 (en) 1992-10-13
ES2091970T3 (es) 1996-11-16
KR970005177B1 (ko) 1997-04-14
TW215899B (it) 1993-11-11
IT1245891B (it) 1994-10-25
US5300300A (en) 1994-04-05
ITBO910114A0 (it) 1991-04-12
DE69213800T2 (de) 1997-02-20
JPH0597677A (ja) 1993-04-20
KR920019360A (ko) 1992-11-19
EP0508312B1 (en) 1996-09-18
DE69213800D1 (de) 1996-10-24
CA2065652C (en) 1999-01-12
JP2509046B2 (ja) 1996-06-19
EP0508312A1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
ITBO910114A1 (it) Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
ITBO910112A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
ITMI931631A0 (it) Composizioni farmaceutiche a rilascio controllato a base di uno o piu'sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
AT400295B (de) Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
DE69621885D1 (de) Neue galenische orale pharmazeutische formulierung
ATE252379T1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
KR900701258A (ko) 결장 선택적 방출성을 갖는 경구용 약제학적 제제
FI935513A (fi) Karboksyylihappojohdannaiset, näitä sistältävät lääkeaineet ja menetelmä niiden valmistamiseksi
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
ZA991982B (en) Salts of keto acids and amine derivatives and their use for the preparation of medicaments.
AU2229392A (en) Method for the preparation of prolonged-release oral pharmaceutical forms containing active substances having a solubility dependent upon the ph value
IT8822902A0 (it) Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
IT9020943A0 (it) Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei
DE69624992D1 (de) Pharmazeutische Zusammensetzungen zum topischen Gebrauch enthaltend Ketoprofen
FI941566A (fi) Suun kautta annettava trimetoprim-liuos
IT8821965A0 (it) Composizioni farmaceutiche orali contenenti sali di destrorfano.
EG19689A (en) New pharmaceutical preparation for oral use
IT8721255A0 (it) 2 tiolpropionil arginine, loro sali, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ITMI931049A1 (it) Composizione farmaceutica mucoadesiva a rilascio controllato per la somministrazione orale di furosemide
ITTO910279A1 (it) Procedimento per la preparazione dell'acido -metil-4-(2-metilpropil) benzeneacetico e dei suoi sali

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423